Physician-authored perspectives on hormone health, metabolic optimization, and what the evidence actually says.
A total testosterone number is a starting point, not a diagnosis. Free testosterone, SHBG, and estradiol tell a more complete clinical story than the single number your primary care physician may have flagged.
Semaglutide and tirzepatide work differently from every diet you have tried before. Understanding the mechanism helps set realistic expectations and makes the first three months significantly more manageable.
Symptom-based treatment without objective data is guesswork. A comprehensive baseline panel is not a formality at Sauzule. It is the clinical foundation every protocol is built on.
Not every man with suboptimal testosterone is a candidate for replacement therapy. Lifestyle factors, secondary hypogonadism, and fertility considerations all shape the right clinical approach for each patient.
The conversation around hormone replacement therapy for women has shifted significantly over the past decade. What the current evidence supports, and why the old fear was largely misplaced.
Sermorelin is not growth hormone. It is a secretagogue that signals the pituitary to produce more of your own. Understanding that distinction matters for setting expectations and evaluating whether it belongs in your protocol.